Physician

Kevin Randall Hayes, M.D.

According to 2025 Medicare claims, Kevin Hayes, M.D. (NPI: 1356521421) practices cardiac electrophysiology in the Texarkana, TX-AR market, with the plurality of this provider's patient population coming from Bowie, TX. This provider's primary affiliated billing organization is CHRISTUS TRINITY CLINIC (NPI: 1285684225; TIN: 752616977) and primary practice location at 75503-2372. Hayes is affiliated with the CHRISTUS Health Quality Care Alliance (ACO ID: A3029), participating under the MSSP model.

Hayes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,235 traditional Medicare patients, billed 5,616 HCPCS/CPT codes, and received $391,214 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,147 prescription claims across 838 beneficiaries totaling $1,078,613 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 12 claims. Open Payments data shows 44 records totaling $632. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $12,503 to $1,078,613. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	286	807	$77,105
2016	1,108	4,433	$407,218
2017	1,037	5,654	$512,658
2018	1,206	7,290	$606,388
2019	1,448	7,523	$556,121
2020	1,558	7,376	$532,865
2021	1,288	8,261	$582,280
2022	1,146	6,478	$467,827
2023	1,190	6,660	$427,857
2024	1,235	5,616	$391,214

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	57	170	$12,503
2016	228	1,176	$116,571
2017	288	1,642	$192,776
2018	391	2,403	$285,761
2019	458	3,316	$423,427
2020	509	3,357	$579,761
2021	601	3,598	$710,061
2022	668	4,101	$892,275
2023	762	4,463	$1,036,107
2024	838	4,147	$1,078,613

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$20,475
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$26,142
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	451	486	$71
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	265	294	$55
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	437	756	$20
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	239	266	$8
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	475	576	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	775	40,536	$766,926
Entresto	Sacubitril/Valsartan	135	6,965	$150,459
Xarelto	Rivaroxaban	66	3,235	$57,360
Multaq	Dronedarone Hcl	17	1,290	$32,244
Sotalol	Sotalol Hcl	313	22,515	$6,105

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$632	Biosense Webster, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kevin Randall Hayes, M.D.?

Tedicare shows public-source Medicare data for Kevin Randall Hayes, M.D. (NPI 1356521421), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin Randall Hayes, M.D. have ACO affiliation data?

Kevin Randall Hayes, M.D. is shown with ACO affiliation data for CHRISTUS Health Quality Care Alliance (MSSP, ACO ID A3029).

What billing organization is linked to Kevin Randall Hayes, M.D.?

Kevin Randall Hayes, M.D. is linked to CHRISTUS TRINITY CLINIC (billing NPI 1285684225) in the available physician profile data.

Does Kevin Randall Hayes, M.D. have Open Payments data?

Kevin Randall Hayes, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.